Angiodynamics (ANGO) Other Non Operating Income (2010 - 2026)
Angiodynamics' (ANGO) quarterly Other Non Operating Income came in at -$735000.0 in Q2 2026, down 126.15% YoY from $2.8 million in Q2 2025, and down 114.8% on a QoQ basis from $5.0 million in Q1 2026.
Angiodynamics (ANGO) Other Non Operating Income (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 17 years of Other Non Operating Income data on file, last reported at -$735000.0 in Q2 2026.
- Quarterly Other Non Operating Income fell 126.15% year-over-year to -$735000.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $3.9 million (down 20.59% YoY) and the FY2026 annual result came in at $3.9 million, down 20.59% from the prior year.
- Other Non Operating Income eased to -$735000.0 in Q2 2026, from $5.0 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $5.4 million in Q1 2025 to a low of -$735000.0 in Q2 2026.
- A 5-year average of $415941.2 and a median of -$175000.0 in 2022 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income plunged 2420.0% — and 2025, when it jumped 2381.51%.
- Tracing ANGO's Other Non Operating Income over 5 years: stood at -$252000.0 in 2022, then soared by 87.3% to -$32000.0 in 2023, then jumped by 137.5% to $12000.0 in 2024, then sank by 1166.67% to -$128000.0 in 2025, then tumbled by 474.22% to -$735000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$735000.0 (Q2 2026), $5.0 million (Q1 2026), and -$128000.0 (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Angiodynamics | 655.49 Mn | 601.62 Mn | 46.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -735,000.00 |
| Feb 28, 2026 | 4.97 Mn |
| Nov 30, 2025 | -128,000.00 |
| Aug 31, 2025 | -178,000.00 |
| May 31, 2025 | -325,000.00 |
| Feb 28, 2025 | 5.43 Mn |
| Nov 30, 2024 | 12,000.00 |
| Aug 31, 2024 | -173,000.00 |
| May 31, 2024 | -259,000.00 |
| Feb 29, 2024 | -238,000.00 |
| Nov 30, 2023 | -32,000.00 |
| Aug 31, 2023 | -288,000.00 |
| May 31, 2023 | -127,000.00 |
| Nov 30, 2022 | -252,000.00 |
| Aug 31, 2022 | -175,000.00 |
| May 31, 2022 | -139,000.00 |
| Feb 28, 2022 | -289,000.00 |
| Nov 30, 2021 | -10,000.00 |
| Aug 31, 2021 | -352,000.00 |
| May 31, 2021 | -167,000.00 |